BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4468254)

  • 1. Tumorigenicity and anti-cancer properties of n-hydroxy urethan.
    Bhide SV; Khandalekar DD; Chitnis MP; Arjungi KN; Sirsat MV
    Indian J Cancer; 1974 Dec; 11(4):462-6. PubMed ID: 4468254
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-cancer activity of the extracts of stem and leaf of Tylophora indica.
    Chitnis MP; Khandalekar DD; Adwankar MK; Sahasrabudhe MB
    Indian J Med Res; 1972 Mar; 60(3):359-62. PubMed ID: 4659916
    [No Abstract]   [Full Text] [Related]  

  • 3. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.
    Schwartz HS; Grindey GB
    Cancer Res; 1973 Aug; 33(8):1837-44. PubMed ID: 4720795
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative carcinogenicities and mutagenicities of vinyl carbamate, ethyl carbamate, and ethyl N-hydroxycarbamate.
    Dahl GA; Miller EC; Miller JA
    Cancer Res; 1980 Apr; 40(4):1194-203. PubMed ID: 7357549
    [No Abstract]   [Full Text] [Related]  

  • 5. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
    Avery TL; Roberts D
    Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
    [No Abstract]   [Full Text] [Related]  

  • 7. The predictive value of skin allograft survival times during the development of urethan-induced lung adenomas in BALB-c mice.
    Lappé MA; Prehn RT
    Cancer Res; 1970 May; 30(5):1357-61. PubMed ID: 4913341
    [No Abstract]   [Full Text] [Related]  

  • 8. Production of leukemia and stomach neoplasms in Swiss, RF, BALB-c, and C3H female mice by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
    Cohen SM; Ertürk E; Bryan GT
    Cancer Res; 1970 Sep; 30(9):2320-5. PubMed ID: 5475478
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
    Razek A; Vietti T; Valeriote F
    Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of Brucella abortus infection on the development of Rauscher and L1210 leukemias in mice].
    Veskova TK; Chimishkian KL; Svet-Moldavskiĭ GIa
    Vopr Virusol; 1973; 18(6):728-31. PubMed ID: 4789989
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation, in newborn Swiss mice, of the carcinogenic activity of some antineoplastic and immunosuppressive compounds].
    Brambilla G; Caraceni CE; Cavanna M; Parodi S
    Boll Soc Ital Biol Sper; 1971 Jul; 47(14):418-22. PubMed ID: 5134218
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor activity and some pharmacologic properties of anthramycin methyl ether.
    Adamson RH; Hart LG; DeVita VT; Oliverio VT
    Cancer Res; 1968 Feb; 28(2):343-7. PubMed ID: 5641523
    [No Abstract]   [Full Text] [Related]  

  • 13. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
    Chaparas SD; Chirigos M; Pearson J; Sher N
    Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antileukemic activity of carminomycin complexes with a high-polymer DNA].
    Vaĭnberg IuP; Egorov LV; Kuznetsova TV; Rudneva NA; Khanykova OK
    Antibiotiki; 1980 Jun; 25(6):454-8. PubMed ID: 7396445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse.
    Yancey ST; Bleyer WA
    Cancer Res; 1974 Aug; 34(8):1866-9. PubMed ID: 4526157
    [No Abstract]   [Full Text] [Related]  

  • 16. R17934-NSC 238159: a new antitumor drug--I. Effect on experimental tumors and factors influencing effectiveness.
    Atassi G; Tagnon HJ
    Eur J Cancer (1965); 1975 Sep; 11(9):599-607. PubMed ID: 1220975
    [No Abstract]   [Full Text] [Related]  

  • 17. The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone.
    French FA; Blanz EJ
    Cancer Res; 1965 Oct; 25(9):1454-8. PubMed ID: 5862990
    [No Abstract]   [Full Text] [Related]  

  • 18. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination radiotherapy and chemotherapy for P388 lymphocytic leukemia in vivo.
    Wodinsky I; Swiniarski J; Kensler CJ; Venditti JM
    Cancer Chemother Rep 2; 1974 Mar; 4(1):73-97. PubMed ID: 4826500
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of zinc administration on the growth of L1210 and BW5147 tumors in mice.
    Phillips JL; Sheridan PJ
    J Natl Cancer Inst; 1976 Aug; 57(2):361-3. PubMed ID: 1003517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.